CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) invested over $114 million in affordable housing in 2020, aiming to improve community health for vulnerable populations. This funding will support the construction and rehabilitation of more than 2,800 affordable housing units across 30 cities in 12 states. Key initiatives include 460 permanent supportive housing units for individuals facing homelessness or health challenges. Additionally, the company has committed nearly $600 million over five years to address racial inequality in Black communities and improve overall health access and economic support.
CVS Health (NYSE: CVS) has unveiled a community-based strategy aimed at addressing COVID-19 vaccine access inequities, focusing on Black and Hispanic populations. This initiative includes proactive outreach, partnerships, and vaccine clinics, with nearly 10,000 CVS locations nationwide serving as key sites. By prioritizing areas with high social vulnerability, CVS aims to educate and connect underserved communities with vaccination services. The effort includes collaborations with nonprofits and a significant marketing campaign to boost vaccine education and confidence.
CVS Health reported full-year 2020 total revenues of $268.7 billion, a 4.6% increase from 2019. GAAP diluted EPS for 2020 was $5.47, while adjusted EPS stood at $7.50. COVID-19 significantly impacted operations, with net income decreasing 44.1% in Q4 compared to 2019, primarily due to a $674 million loss on early debt extinguishment. The company anticipates 2021 GAAP diluted EPS between $6.06 and $6.22. CVS has administered 15 million COVID-19 tests and 3 million vaccines, demonstrating its role in pandemic response.
CVS Health is set to begin administering COVID-19 vaccines at 17 pharmacy locations in South Carolina on February 11. This limited rollout will provide approximately 15,300 doses sourced from a federal pharmacy partnership program. Appointments can be booked starting February 9. The initiative is part of a larger multi-state rollout, including approximately 335 locations across various states, with a goal to eventually administer 20-25 million shots per month. CVS Health continues to expand vaccine accessibility while supporting long-term care facilities.
CVS Health is set to administer COVID-19 vaccines starting February 11, 2021, at 28 pharmacy locations in Virginia. Approximately 26,000 doses will be available through the federal pharmacy partnership program. Appointments can be booked beginning February 9. This vaccine rollout is part of an initial plan covering 11 states, with CVS capable of administering 20-25 million shots monthly. CVS also advances vaccination efforts at over 870 long-term care facilities across Virginia, aiming for complete first doses by mid-February. The company highlights its community presence as key to effective vaccination.
CVS Health is set to begin administering COVID-19 vaccines at 32 pharmacy locations across New York starting February 11, 2021. Appointments can be booked from February 9, with a total supply of approximately 20,600 doses. The initiative is part of a broader 11-state rollout and aims to expand as vaccine supplies increase. CVS focuses on community presence for efficient vaccine distribution. The company is also vaccinating residents at over 1,200 long-term care facilities in New York, with first doses expected to be completed by mid-February.
CVS Health will begin administering COVID-19 vaccines on February 11 at four pharmacy locations in Rhode Island. Appointments can be booked starting February 9 with 3,400 doses available. This initiative is part of a broader rollout across 11 states and aims to leverage CVS's community presence for vaccine distribution. The company plans to expand as more doses become available, with a capacity to administer up to 25 million shots monthly. CVS is also vaccinating residents in over 200 long-term care facilities in Rhode Island.
CVS Health will begin administering COVID-19 vaccines at 70 pharmacy locations in Texas starting February 11, 2021. Approximately 38,000 doses will be available initially, with appointments open for booking on February 9. The rollout is part of an 11-state initiative, with plans to expand as vaccine supply increases. CVS aims to provide 20-25 million shots monthly nationwide, emphasizing community access to vaccines. Additionally, CVS is progressing with vaccination efforts in over 2,000 long-term care facilities in Texas, aiming to complete first doses by mid-February.
CVS Health is set to administer COVID-19 vaccines starting on February 11 at 18 locations in Massachusetts. This initiative is part of a broader rollout across 11 states, with approximately 21,600 doses available. Appointments for vaccinations can be booked from February 9. CVS aims to administer 20-25 million shots monthly as supply increases. The company is also vaccinating staff and residents at over 1,900 long-term care facilities in the state, with first doses expected to be completed by mid-February.
CVS Health will start administering COVID-19 vaccines at 27 pharmacy locations in New Jersey on February 11, 2021. Appointments can be booked from February 9, with approximately 19,900 doses available for the initial rollout. The company is part of a broader initiative to provide vaccines across 11 states, aiming to eventually administer 20-25 million shots per month. Vaccines will be offered to eligible individuals as per state guidelines, with a focus on safety and community presence.